نتائج البحث - Emilio Suárez

  • يعرض 1 - 4 نتائج من 4
تنقيح النتائج
  1. 1
    Consensus document of the Spanish Association for Study of the Liver on the treatment of hepatitis B virus infection (2020)

    Consensus document of the Spanish Association for Study of the Liver on the treatment of hepatitis B virus infection (2020) حسب Manuel Rodríguez, Marı́a Buti, Rafael Esteban, Sabela Lens, M. Prieto, Emilio Suárez, Javier García‐Samaniego

    منشور في 2020
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    Tenofovir Is Effective Alone or With Emtricitabine in Adefovir-Treated Patients With Chronic-Hepatitis B Virus Infection

    Tenofovir Is Effective Alone or With Emtricitabine in Adefovir-Treated Patients With Chronic-Hepatitis B Virus Infection حسب Thomas Berg, Patrick Marcellin, Fabien Zoulim, Bernd Möller, Huy N. Trinh, Sing Chan, Emilio Suárez, Fabien Lavocat, Andrea Snow‐Lampart, David Frederick, J. Sorbel, Katyna Borroto–Esoda, David Oldach, Franck Rousseau

    منشور في 2010
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    Randomized prospective study evaluating tenofovir disoproxil fumarate prophylaxis against hepatitis B virus reactivation in anti-HBc-positive patients with rituximab-based regimens to treat hematologic malignancies: The Preblin study

    Randomized prospective study evaluating tenofovir disoproxil fumarate prophylaxis against hepatitis B virus reactivation in anti-HBc-positive patients with rituximab-based regimens... حسب Marı́a Buti, María Luisa Manzano, Rosa M. Morillas, Montserrat García–Retortillo, Leticia Martín, M. Prieto, María Luisa Gutiérrez García, Emilio Suárez, Mariano Gómez Rubio, Javier López, Pilar Castillo, Manuel Rodríguez, José Manuel Zozaya, Miguel Ángel Simón, Luís Morano, José Luís Calleja, Mireia Yébenes, Rafael Esteban

    منشور في 2017
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  4. 4
    Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients

    Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients حسب Manuel Romero‐Gómez, María del Mar Viloria, Raúl J. Andrade, Javier Salmerón, M. Diago, Conrado Fernández‐Rodríguez, Raquel Corpas, Marina Cruz, Lourdes Grande, Luis Alberto Vázquez, Paloma Muñoz‐de‐Rueda, Pilar López Serrano, A. Gila, María Luisa Gutiérrez García, Celia Pérez, A. Ruiz‐Extremera, Emilio Suárez, Jesús Castillo

    منشور في 2005
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: